People who suffer from migraine can attest that the condition somewhat affects their quality of life. When the pain occurs frequently or is more chronic, the sufferer becomes frustrated, sad or even angry. In some people, migraine attacks are accompanied by various neurological and vascular symptoms, while others experience gastrointestinal disturbances like irritable bowel syndrome (IBS).
The good news is, migraine patients with IBS may find relief in an immunoglobulin G (IgG)-based food elimination diet.
According to a team researchers from Acibaden University School of Medicine in Istanbul, IgG-based elimination diet reduces the severity and frequency of both migraine headaches and IBS symptoms when compared to regular or provocation diets.
The researchers, led by Dr. Elif Ilgaz Aydinlar, evaluated the therapeutic potential of the immunoglobulin G (IgG)-based elimination diet among 21 patients diagnosed with migraine and IBS. All patients received a blood test to determine their susceptibility to 270 different food allergens, and underwent elimination diet (wherein they avoided foods that their blood work showed they were sensitive to) and provocation diet (wherein they ate foods that their blood work showed they were sensitive to). Each patient was evaluated four times throughout the course of the study.
Dr. Aydinlar told TestCountry that although the mechanisms of an IgG-mediated food allergy have not been fully made clear, it has been proposed that the production of IgG anti-bodies that produce an inflammation response in the body seems to play in important role in the formation of migraine attacks.
The foods that researchers found people were most intolerant of in the study were seeds and nuts followed by grain containing gluten, spices, fruits and vegetables.
“Our findings indicate that food elimination based on IgG antibodies in migraine patients who suffer from concomitant IBS may effectively reduce symptoms from both disorders with potential savings to the health care system,” Dr. Aydinlar noted. “There are no side effects of this treatment. The treatment is easy to apply and effective. I personally suggest this treatment to the patients who have both disorders at the same time.”
The study, which appeared in the online version of Headache: The Journal of Head and Face Pain on Dec. 6, was also supported by the Immuno Diagnostic Laboratories in Istanbul, Turkey.